The efficacy of liraglutide combined with intragastric balloon on weight loss

Basit Öğe Kaydı
dc.authorid0000-0002-1393-5484
dc.contributor.authorYılmaz, Ahmet
dc.contributor.authorHanlıoğlu, Selin
dc.contributor.authorDemiral, Gökhan
dc.contributor.authorKaratepe, Oğuzhan
dc.date.accessioned2023-12-11T10:04:37Z
dc.date.available2023-12-11T10:04:37Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Genel Cerrahi Ana Bilim Dalı
dc.description.abstractOBJECTIVE: Intragastric balloon placement is an effective method for weight reduction. The aim of this study was to evaluate the efficacy of combining liraglutide with intragastric balloon.METHODS: Initially, demographic data of patients such as age, gender, comorbid diseases, adverse events, initial weight, height, body mass index,percent body fat, and waist-hip ratio were collected. Weight, body mass index, percent body fat, and waist-hip ratio were measured in the second, third, fourth, fifth, and sixth months. Then, intragastric balloon was removed and liraglutide was stopped.RESULTS: A total of 50 patients were included in the study, of whom 28 (56%) were in Group A (intragastric balloon) and 22 (44%) were in Group B (plus liraglutide). Weight change at the time of balloon removal was higher in Group B [median weight change 13.8 (7.8 min to 16.8 max) versus 7.9 (4.8 min to 11.8 max); p<0.01]. When the weight, percent body fat, body mass index, and waist-hip ratio changes were compared according to gender, no significant difference was observed in the groups. Comorbid diseases were hypertension in 7 patients (4 in Group A and 3 in Group B) and diabetes in 9 patients (5 in Group A and 4 in Group B). No statistical significance was found.CONCLUSION: Liraglutide has benefits in terms of weight, percent body fat, and body mass index reduction when administered with intragastric balloon.
dc.identifier.citationYılmaz, A., Hanlıoğlu, S., Demiral, G. ve Karatepe, O. (2023). The efficacy of liraglutide combined with intragastric balloon on weight loss. Revista da Associacao Medica Brasileira, 69(12). https://dx.doi.org/10.1590/1806-9282.20230571
dc.identifier.doi10.1590/1806-9282.20230571
dc.identifier.issn0104-4230
dc.identifier.issn1806-9282
dc.identifier.issue12
dc.identifier.pmid37971120
dc.identifier.scopus2-s2.0-85177991960
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://dx.doi.org/10.1590/1806-9282.20230571
dc.identifier.urihttps://hdl.handle.net/20.500.12511/11976
dc.identifier.volume69
dc.identifier.wos001107321500001en_US
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorYılmaz, Ahmet
dc.language.isoen
dc.publisherAssociacao Medica Brasileira
dc.relation.ispartofRevista da Associacao Medica Brasileiraen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectGlucagon-Like Peptide 1
dc.subjectGastric Balloon
dc.subjectLiraglutide
dc.subjectObesity
dc.subjectBody Weight Changes
dc.titleThe efficacy of liraglutide combined with intragastric balloon on weight loss
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Yilmaz-Ahmet-2023.pdf
Boyut:
223.32 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu